AlphaYouDP
Congress trade
Sen. David Perdue (R-GA) sold $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
David Perdue, U.S. Senator (R-GA), disclosed a sale of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Sep 3, 2019.
The trade happened on Aug 15, 2019, 19 days before it was made public.
BMY has moved +33.7% since the trade date, from $45.75 to $61.15 (Oct 2, 2026 close).
- Traded
- Aug 15, 2019
- Disclosed
- Sep 3, 2019
- Filing delay
- 19 days
- Price since
- +33.7%
- Source
- STOCK Act disclosure
Other trades in this disclosure (30)
- BuyKR$15K-$50KSep 3, 2019
- BuyKR$15K-$50KSep 3, 2019
- SellT$15K-$50KSep 3, 2019
- SellCZR$1K-$15KSep 3, 2019
- SellCZR$1K-$15KSep 3, 2019
- SellCZR$1K-$15KSep 3, 2019
- SellCZR$1K-$15KSep 3, 2019
- SellCZR$1K-$15KSep 3, 2019
- SellDIS$1K-$15KSep 3, 2019
- SellDIS$1K-$15KSep 3, 2019
- SellENTG$1K-$15KSep 3, 2019
- SellENTG$1K-$15KSep 3, 2019
- SellENTG$1K-$15KSep 3, 2019
- SellEXR$1K-$15KSep 3, 2019
- SellEXR$1K-$15KSep 3, 2019
- BuyFEYE$1K-$15KSep 3, 2019
- BuyGPK$1K-$15KSep 3, 2019
- BuyGPK$1K-$15KSep 3, 2019
- BuyGPK$1K-$15KSep 3, 2019
- BuyGPK$1K-$15KSep 3, 2019
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.